Gd-enhanced CMR risk-stratifies in ischemics, nonischemics; clinical value uncertain

Two reports add to the literature showing that gadolinium-enhanced cardiac magnetic resonance imaging can help risk-stratify patients with ischemic and nonischemic cardiomyopathy; one of them added a twist to the debate over the STICH viability study.
Source: theHeart.org - Category: Cardiology Source Type: news